Huanhuan Jin Selected Research

Huanhuan Jin Research Topics

Disease

8	Liver Cirrhosis (Hepatic Cirrhosis) 10/2019 - 03/2016
7	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2023 - 08/2015
7	Fibrosis (Cirrhosis) 12/2022 - 07/2015
6	Inflammation (Inflammations) 01/2023 - 08/2015
4	Liver Diseases (Liver Disease) 11/2019 - 04/2018
3	Neoplasms (Cancer) 01/2023 - 01/2020
2	Alcoholic Fatty Liver 01/2022 - 11/2019
2	Iron Overload 09/2021 - 01/2021
2	Non-alcoholic Fatty Liver Disease 09/2021 - 01/2021
2	Hypoxia (Hypoxemia) 04/2018 - 01/2018
2	Hyperlipidemias (Hyperlipidemia) 12/2015 - 08/2015
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2022
1	Lung Injury 12/2022
1	Bites and Stings (Sting) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Necrosis 11/2019
1	Carcinogenesis 06/2019
1	Vascular Remodeling 01/2018
1	Body Weight (Weight, Body) 01/2016

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2015
5	tetramethylpyrazineIBA 01/2022 - 12/2015
3	Ethanol (Ethyl Alcohol)IBA 01/2023 - 08/2015
3	curcumolIBA 01/2022 - 10/2018
3	5,7- dihydroxy- 6- methoxy- 2- phenylchromen- 4- oneIBA 06/2018 - 01/2018
2	Protein Kinases (Protein Kinase)IBA 01/2022 - 10/2018
2	Thymidine Monophosphate (TMP)IBA 01/2022 - 01/2017
2	Long Noncoding RNAIBA 01/2021 - 01/2020
2	artenimol (dihydroartemisinin)IBA 11/2019 - 03/2016
2	Carbon Tetrachloride (Tetrachloromethane)IBA 10/2018 - 07/2015
2	LipidsIBA 11/2015 - 08/2015
2	CurcuminIBA 08/2015 - 07/2015
1	schizandrin BIBA 01/2023
1	pterostilbeneIBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	Glutathione (Reduced Glutathione)IBA 12/2022
1	Glutamic Acid (Glutamate)FDA Link 12/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 12/2022
1	Glutamine (L-Glutamine)FDA Link 12/2022
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 12/2022
1	Adenosine Triphosphate (ATP)IBA 12/2022
1	tyrosine receptor (receptor, tyrosine)IBA 01/2022
1	ChromatinIBA 01/2022
1	Lamin Type B (Lamin B)IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 09/2021
1	Phosphotransferases (Kinase)IBA 01/2020
1	talazoparibIBA 01/2020
1	Docosahexaenoic AcidsIBA 10/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2019
1	Gallic AcidIBA 06/2019
1	PeriostinIBA 06/2019
1	AcriflavineIBA 01/2018
1	Platelet Endothelial Cell Adhesion Molecule-1IBA 01/2018
1	Angiopoietin-2IBA 01/2018
1	LigandsIBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2018
1	CytokinesIBA 11/2017
1	diallyl trisulfideIBA 01/2017
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 01/2016
1	EnzymesIBA 08/2015
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 08/2015
1	SterolsIBA 08/2015
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 08/2015
1	Biomarkers (Surrogate Marker)IBA 08/2015
1	ElementsIBA 08/2015
1	PPAR alphaIBA 08/2015

Therapy/Procedure

1	Intraperitoneal Injections 11/2017